|
DE3315272C2
(de)
|
1983-04-27 |
1986-03-27 |
Lohmann Gmbh & Co Kg, 5450 Neuwied |
Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
|
|
US4906463A
(en)
*
|
1986-12-22 |
1990-03-06 |
Cygnus Research Corporation |
Transdermal drug-delivery composition
|
|
US5405486A
(en)
|
1988-03-04 |
1995-04-11 |
Noven Pharmaceuticals, Inc. |
Apparatus for forming a transdermal drug device
|
|
US5032207A
(en)
|
1988-03-04 |
1991-07-16 |
Noven Pharmaceuticals, Inc. |
One-step method for forming a pressure-sensitive adhesive transdermal drug device
|
|
US4994278A
(en)
|
1988-03-04 |
1991-02-19 |
Noven Pharmaceuticals, Inc. |
Breathable backing
|
|
US5474783A
(en)
|
1988-03-04 |
1995-12-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
|
US5300291A
(en)
|
1988-03-04 |
1994-04-05 |
Noven Pharmaceuticals, Inc. |
Method and device for the release of drugs to the skin
|
|
US5719197A
(en)
|
1988-03-04 |
1998-02-17 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for topical administration of pharmaceutically active agents
|
|
US5656286A
(en)
|
1988-03-04 |
1997-08-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
|
US4814168A
(en)
|
1988-03-04 |
1989-03-21 |
Noven Pharmaceuticals, Inc. |
Transdermal multipolymer drug delivery system
|
|
US4994267A
(en)
|
1988-03-04 |
1991-02-19 |
Noven Pharmaceuticals, Inc. |
Transdermal acrylic multipolymer drug delivery system
|
|
ES2097145T3
(es)
|
1990-03-28 |
1997-04-01 |
Noven Pharma |
Metodo y dispositivo para la liberacion de farmacos en la piel.
|
|
AU2004092A
(en)
|
1991-04-25 |
1992-12-21 |
Noven Pharmaceuticals, Inc. |
Method and apparatus for forming a transdermal drug device
|
|
US5387189A
(en)
|
1993-12-02 |
1995-02-07 |
Alza Corporation |
Electrotransport delivery device and method of making same
|
|
CN1153361C
(zh)
|
1998-03-20 |
2004-06-09 |
皇家菲利浦电子有限公司 |
具有时钟信号发生器的接收器
|
|
DE19814084B4
(de)
|
1998-03-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
|
|
US6757560B1
(en)
|
1999-04-09 |
2004-06-29 |
Novosis Pharma Ag |
Transdermal delivery system (TDS) with electrode network
|
|
US7655249B2
(en)
|
1998-09-30 |
2010-02-02 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
|
US6317630B1
(en)
|
1999-01-29 |
2001-11-13 |
Yossi Gross |
Drug delivery device
|
|
DK1189660T3
(da)
|
1999-06-08 |
2006-08-21 |
Altea Therapeutics Corp |
Apparat til mikroperforering af biologiske membraner ved hjælp af tyndfilms-vævsgrænseflade-anordninger samt fremgangsmåde til fremstilling deraf
|
|
CN1195505C
(zh)
|
1999-07-02 |
2005-04-06 |
Lts勒曼治疗系统股份公司 |
以聚硅氧烷及亲两性溶剂为基础的微贮存系统
|
|
DE10012908B4
(de)
|
2000-03-16 |
2005-03-17 |
Lts Lohmann Therapie-Systeme Ag |
Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
|
|
DE10041479A1
(de)
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
|
|
US6682757B1
(en)
|
2000-11-16 |
2004-01-27 |
Euro-Celtique, S.A. |
Titratable dosage transdermal delivery system
|
|
EP1381358B1
(en)
|
2001-04-02 |
2006-05-03 |
Astrazeneca AB |
Solid pharmaceutical composition comprising 4'-cyano-trifluoro-3-(4-fluorophenylsulphonyl) -2-hydroxy-2-methylpropiono- m toluidide and pvp
|
|
DE10118282A1
(de)
|
2001-04-12 |
2002-12-05 |
Lohmann Therapie Syst Lts |
Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke
|
|
ATE246919T1
(de)
|
2001-05-08 |
2003-08-15 |
Sanol Arznei Schwarz Gmbh |
Verbessertes transdermales therapeutisches system zur behandlung von morbus parkinson
|
|
EP1256339B1
(en)
|
2001-05-08 |
2003-10-15 |
Schwarz Pharma Ag |
Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine
|
|
US20030026830A1
(en)
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
|
|
DE10141651B4
(de)
|
2001-08-24 |
2007-02-15 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
|
|
CA2460352C
(en)
|
2001-08-17 |
2013-05-14 |
Lavipharm Laboratories Inc. |
Composition and transdermal drug delivery device
|
|
DE10159745A1
(de)
|
2001-12-05 |
2003-07-03 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
|
|
US6775570B2
(en)
|
2002-02-04 |
2004-08-10 |
Ceramatec, Inc. |
Iontophoretic treatment device
|
|
US20030180281A1
(en)
|
2002-03-11 |
2003-09-25 |
Bott Richard R. |
Preparations for topical skin use and treatment
|
|
US20060263419A1
(en)
|
2002-03-12 |
2006-11-23 |
Hans-Michael Wolff |
Transdermal therapeutic system for Parkinson's Disease
|
|
DE10220230A1
(de)
|
2002-05-06 |
2003-11-27 |
Sanol Arznei Schwarz Gmbh |
Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
|
|
EP1386604A1
(en)
|
2002-07-30 |
2004-02-04 |
Schwarz Pharma Ag |
Improved transdermal delivery system
|
|
US8211462B2
(en)
*
|
2002-07-30 |
2012-07-03 |
Ucb Pharma Gmbh |
Hot-melt TTS for administering rotigotine
|
|
DE10234673B4
(de)
|
2002-07-30 |
2007-08-16 |
Schwarz Pharma Ag |
Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
|
|
EP1386605A1
(en)
|
2002-07-30 |
2004-02-04 |
Schwarz Pharma Ag |
Improved transdermal delivery system for the administration of rotigotine
|
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
|
ES2239196T3
(es)
|
2002-12-02 |
2005-09-16 |
Schwarz Pharma Ag |
Suministro iontoforetico de rotigotina para el tratamiento de la enfermedad de parkinson.
|
|
DE10261696A1
(de)
|
2002-12-30 |
2004-07-15 |
Schwarz Pharma Ag |
Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
|
|
US7603144B2
(en)
|
2003-01-02 |
2009-10-13 |
Cymbet Corporation |
Active wireless tagging system on peel and stick substrate
|
|
WO2004061887A1
(en)
|
2003-01-02 |
2004-07-22 |
Cymbet Corporation |
Solid-state battery-powered devices and manufacturing methods
|
|
CN100512806C
(zh)
|
2003-04-14 |
2009-07-15 |
Lts勒曼治疗系统股份公司 |
具有包含辣椒碱的聚硅氧烷基质的治疗贴剂
|
|
JP2007522262A
(ja)
|
2003-06-26 |
2007-08-09 |
シミックス・テクノロジーズ・インコーポレイテッド |
フォトレジストポリマー
|
|
WO2005009417A1
(en)
|
2003-07-21 |
2005-02-03 |
Noven Pharmaceuticals, Inc. |
Composition and method for controlling grug delivery from silicone adhesive blends
|
|
DE10334188B4
(de)
|
2003-07-26 |
2007-07-05 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung von Depressionen
|
|
EP1547592A1
(en)
|
2003-12-23 |
2005-06-29 |
Schwarz Pharma Ag |
Intranasal formulation of rotigotine
|
|
DE10361259A1
(de)
|
2003-12-24 |
2005-07-28 |
Schwarz Pharma Ag |
Verwendung von Rotigotine in einem Frühstadium von Morbus Parkinson zur Prävention des weiteren Neuronenverlustes
|
|
US20050202073A1
(en)
*
|
2004-03-09 |
2005-09-15 |
Mylan Technologies, Inc. |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
|
US9205062B2
(en)
|
2004-03-09 |
2015-12-08 |
Mylan Pharmaceuticals, Inc. |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
|
DE102004014841B4
(de)
|
2004-03-24 |
2006-07-06 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
|
|
WO2005119610A1
(en)
|
2004-05-28 |
2005-12-15 |
Jan De Geest |
Communication unit for a person's skin
|
|
JP2006178807A
(ja)
|
2004-12-24 |
2006-07-06 |
Echigo Fudagami Kk |
Ｉｃシート製造装置及びｉｃシート製造方法
|
|
GB0506139D0
(en)
|
2005-03-24 |
2005-05-04 |
Transphase Ltd |
A transdermal topical composition and its uses
|
|
TWI389709B
(zh)
|
2005-12-01 |
2013-03-21 |
Novartis Ag |
經皮治療系統
|
|
DE102006054731B4
(de)
|
2006-11-21 |
2013-02-28 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
|
|
DE102006054733A1
(de)
|
2006-11-21 |
2008-05-29 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit
|
|
CN101147739B
(zh)
|
2007-07-06 |
2010-12-08 |
北京康倍得医药技术开发有限公司 |
含罗替戈汀的组合物及其制药用途以及含该组合物的透皮贴剂
|
|
JP2010536434A
(ja)
|
2007-08-17 |
2010-12-02 |
イシス バイオポリマー エルエルシー |
イオン泳動薬物送達システム
|
|
US20100311661A1
(en)
|
2007-08-24 |
2010-12-09 |
Max Planck Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Use of compounds derived from cycloheximide for the treatment or prevention of, in particular, ischaemias and cardiopathies
|
|
PE20091041A1
(es)
|
2007-10-19 |
2009-08-22 |
Abbott Gmbh & Co Kg |
Producto de dispersion solida que contiene un compuesto a base de n-aril urea
|
|
NZ584363A
(en)
|
2007-11-28 |
2012-11-30 |
Ucb Pharma Gmbh |
Drug formulations of Rotigotine which comprise the thermodynamically stable polymorphic form 2
|
|
CA2726136C
(en)
|
2008-05-30 |
2016-11-01 |
Mylan Laboratories, Inc. |
Stabilized transdermal drug delivery system
|
|
JP2009297808A
(ja)
|
2008-06-11 |
2009-12-24 |
Chiyoda Integre Co Ltd |
粘着テープ製造方法及び粘着テープ製造装置
|
|
EP2140861A1
(en)
|
2008-06-30 |
2010-01-06 |
Abbott GmbH & Co. KG |
Pharmaceutical dosage form comprising polymeric carrier composition
|
|
AR074047A1
(es)
|
2008-09-09 |
2010-12-22 |
Transcu Ltd |
Sistemas, dispositivos, y metodos para suministrar energia a dispositivos, por ejemplo dispositivos de administracion transdermica y/o para controlarlos
|
|
AU2009302853B2
(en)
|
2008-10-06 |
2014-09-11 |
Mylan Technologies, Inc. |
Amorphous rotigotine transdermal system
|
|
CA2760467A1
(en)
|
2009-05-08 |
2010-11-11 |
Isis Biopolymer, Inc. |
Iontophoretic device with improved counterelectrode
|
|
EP2281559A1
(en)
|
2009-06-26 |
2011-02-09 |
UCB Pharma GmbH |
Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis
|
|
DE102009052972A1
(de)
|
2009-11-12 |
2011-09-15 |
Lts Lohmann Therapie-Systeme Ag |
Verfahren zur Verhinderung der Kristallisation von Arzneistoffen in einem Polymerfilm
|
|
LT3257504T
(lt)
|
2009-12-22 |
2024-08-26 |
UCB Biopharma SRL |
Polivinilpirolidonas, skirtas nekristalinės formos kietos rotigotino dispersijos stabilizavimui
|
|
AU2011332187B2
(en)
|
2010-11-23 |
2016-03-03 |
Teva Pharmaceuticals International Gmbh |
User-activated self-contained co-packaged iontophoretic drug delivery system
|
|
WO2012084969A1
(en)
*
|
2010-12-22 |
2012-06-28 |
Hexal Ag |
Adhesive composition containing rotigotine and transdermal therapeutic system comprising the adhesive composition
|
|
WO2013075823A1
(en)
|
2011-11-22 |
2013-05-30 |
Alfred E. Tiefenbacher (Gmbh & Co. Kg) |
Transdermal therapeutic system comprising rotigotine and crystallization inhibitor
|
|
DE102012013421A1
(de)
|
2012-07-03 |
2014-01-09 |
Alfred E. Tiefenbacher (Gmbh & Co. Kg) |
Transdermales therapeutisches System (TTS) mit Rotigotin
|
|
EA201491164A1
(ru)
|
2011-12-12 |
2014-10-30 |
ЭлТиЭс ЛОМАНН ТЕРАПИ-ЗЮСТЕМ АГ |
Трансдермальная система доставки
|
|
TW201431570A
(zh)
|
2012-11-22 |
2014-08-16 |
Ucb Pharma Gmbh |
用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
|
|
AP2015008920A0
(en)
|
2013-06-04 |
2015-12-31 |
Lohmann Therapie Syst Lts |
Transdermal delivery system
|